Evidence map›Paper›PMID 33178021›Full record

ArticleFrontiers in pharmacology2020

Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease.

Devinder Toor, Aklank Jain, Shivani Kalhan, Harmesh Manocha, Vivek Kumar Sharma, Payal Jain, Vishwas Tripathi, Hridayesh Prakash

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Innate immunity to SARS-CoV-2 infection: a review.Epidemiology and infection · 2022
    Pooled it
  2. Immunity and Coagulation in COVID-19.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Review
  5. SARS-CoV-2 Spike Protein Activates Human Lung Macrophages.International journal of molecular sciences · 2023
    Article
  6. Initial immune response after exposure toFrontiers in immunology · 2023
    Review
  7. Review
  8. Article
  9. SARS-CoV-2 Infection and Lung Regeneration.Clinical microbiology reviews · 2022
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Devinder ToorAmity Institute of Virology and Immunology, Amity University Uttar Pradesh, Noida, India.
Aklank JainDepartment of Zoology, Central University of Punjab, Bathinda, India.
Shivani KalhanDepartment of Pathology, Government Institute of Medical Sciences, Greater Noida, India.
Harmesh ManochaDepartment of Microbiology, Government Institute of Medical Sciences, Greater Noida, India.
Vivek Kumar SharmaDepartment of Physiology, Government Institute of Medical Sciences, Greater Noida, India.
Payal JainDepartment of Medicine, Government Institute of Medical Sciences, Greater Noida, India.
Vishwas TripathiSchool of Biotechnology, Gautam Buddha University, Greater Noida, India.
Hridayesh PrakashAmity Institute of Virology and Immunology, Amity University Uttar Pradesh, Noida, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adoptive immunotheraoyAnti viral activityCD8+T cellsCOVID 19 infectionM1/ M2 macrophages

Identifiers

PMID33178021
PMCPMC7596271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.